首页 > 用药指导 > 文章详情

Baricitinib(艾乐明)巴瑞替尼正确用法用量

发布时间:2024-03-26 08:11:02 阅读:1545 来源:问药网
分享至

分享到微信朋友圈

×

打开微信,点击底部的“发现”,

使用“扫一扫”即可将网页分享至朋友圈。

巴瑞替尼片

巴瑞替尼片 生产厂家:孟加拉碧康制药股份有限公司 功能主治:对一种或多种抗风湿药物缓解不足或不耐受的中度至重 用法用量:用法用量  1、类风湿性关节炎  OLUMIANT的推荐剂量为每日1次口服2mg,餐前餐后都可。  OLUMIANT可以单独使用,也可以与甲氨蝶呤或其他非生物dmard联合使用。  2、COVID-19(新冠病毒)  成人OLUMIANT的推荐剂量为每日一次口服4mg,餐前餐后都可,持续14天或直到出院,以先发生者为准。  3、斑秃  OLUMIANT的推荐剂量是2mg,每天一次口服,餐前餐后都可。  如果对治疗的反应不充分,增加到每天一次4mg。  对于几乎完全或完全的头皮脱发,睫毛或眉毛有或没有大量脱发的患者,考虑每天一次4mg治疗,伴餐前餐后都可。  一旦患者对4mg的治疗产生了充分的反应,将剂量减少到2mg,每天一次。  对于无法吞下整片药片的患者,可以考虑另一种给药方式:  1、口服分散  2、胃造口管(G管)  3、鼻胃管(NG管)或口胃管(OG管)
查看详情

Baricitinib(艾乐明)巴瑞替尼正确用法用量,Baricitinib(Baricitinib)治疗方式不同,用法不同,如:1、治疗类风湿性关节炎:推荐剂量为每日1次口服2mg,餐前餐后都可;2、治疗COVID-19病毒:推荐剂量为每日一次口服4mg,餐前餐后都可;3、治疗斑秃:推荐剂量是每天一次口服2mg,餐前餐后都可。

Baricitinib (trade name Olumiant) is a medication that has shown effectiveness in the treatment of various conditions including rheumatoid arthritis, COVID-19, and alopecia areata (spot baldness). This article aims to provide accurate information about the correct usage and dosage of Baricitinib, also known as Baricitinib tablets.

1. Introduction

Baricitinib, also known as Olumiant, is a medication primarily used for the treatment of moderate to severe rheumatoid arthritis in adults. It belongs to a class of drugs called Janus kinase (JAK) inhibitors, which work by suppressing the immune system and reducing inflammation. Baricitinib is an oral tablet that can be taken once daily with or without food. However, it is crucial to follow the prescribed dosage and usage instructions provided by a healthcare professional.

2. Correct Usage of Baricitinib

When taking Baricitinib, it is important to adhere to the following instructions:

Take the medication exactly as prescribed by your doctor.

Swallow the tablet whole with a glass of water and do not crush, chew, or split it.

Baricitinib can be taken with or without food, according to your preference.

If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and resume your normal schedule. Do not double the dose to make up for a missed one.

3. Recommended Dosage of Baricitinib

The recommended dosage of Baricitinib may vary depending on the condition being treated. The typical dosage for rheumatoid arthritis is 2 mg once daily. However, your healthcare provider may adjust the dosage based on your response to treatment and any side effects you may experience. It is important to follow your doctor's instructions and not exceed the prescribed dosage.

4. Baricitinib in COVID-19 Treatment

Baricitinib has also been studied for its potential use in treating COVID-19, specifically in hospitalized patients requiring supplemental oxygen or ventilation. The dosage in this context may differ from that used for rheumatoid arthritis. The use of Baricitinib for COVID-19 treatment should be under the supervision of a healthcare professional, as it is prescribed along with other medications and the dosage may vary.

5. Baricitinib for Alopecia Areata

Recent research has shown promising results regarding the use of Baricitinib in treating alopecia areata, a condition characterized by patchy hair loss. The dosage and treatment duration for alopecia areata may differ from that used for rheumatoid arthritis. If you are considering Baricitinib for alopecia areata, it is essential to consult with a dermatologist or a healthcare professional experienced in treating hair loss conditions.

It is important to note that Baricitinib, like any medication, may have potential side effects and interactions with other drugs. Therefore, it is crucial to consult with your healthcare provider before starting Baricitinib to ensure its appropriate use and determine if it is the right treatment option for your specific condition.

In conclusion, Baricitinib (Olumiant) is an effective medication used to treat rheumatoid arthritis, COVID-19, and alopecia areata. By following the correct usage and dosage instructions provided by your healthcare professional, you can maximize the benefits of Baricitinib while minimizing the risks associated with its use. Always consult a healthcare provider before starting or adjusting any medication regimen.

孟加拉碧康制药股份有限公司碧康制药股份有限公司(Beacon,简称碧康制药)创建设于2001年,是孟加拉目前规模最大、技术最先进的抗肿瘤类和抗病毒类药物生产企业,也是该国成长最快的大型制药龙头企业。
直达企业主页

热门文章

更多